Trial intelligence / Profile preview

Melatonin for cytokine network normalization and oxidative stress balance in methamphetamine-induced psychosis

TCTR20240529005Phase 3Completed

Sponsor
Chulalongkorn University
Start
Jul 2025
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of melatonin, sponsored by Chulalongkorn University. Started Jul 2025; status: completed.

02

Drugs

melatonin

Beyond the preview

Go deeper on TCTR20240529005.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20240529005.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call